1. Home
  2. SNDX vs PNTG Comparison

SNDX vs PNTG Comparison

Compare SNDX & PNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNDX
  • PNTG
  • Stock Information
  • Founded
  • SNDX 2005
  • PNTG 2019
  • Country
  • SNDX United States
  • PNTG United States
  • Employees
  • SNDX N/A
  • PNTG N/A
  • Industry
  • SNDX Biotechnology: Pharmaceutical Preparations
  • PNTG Medical/Nursing Services
  • Sector
  • SNDX Health Care
  • PNTG Health Care
  • Exchange
  • SNDX Nasdaq
  • PNTG Nasdaq
  • Market Cap
  • SNDX 1.1B
  • PNTG 911.6M
  • IPO Year
  • SNDX 2016
  • PNTG N/A
  • Fundamental
  • Price
  • SNDX $13.08
  • PNTG $27.46
  • Analyst Decision
  • SNDX Strong Buy
  • PNTG Buy
  • Analyst Count
  • SNDX 10
  • PNTG 4
  • Target Price
  • SNDX $36.20
  • PNTG $36.75
  • AVG Volume (30 Days)
  • SNDX 2.6M
  • PNTG 254.9K
  • Earning Date
  • SNDX 02-25-2025
  • PNTG 02-26-2025
  • Dividend Yield
  • SNDX N/A
  • PNTG N/A
  • EPS Growth
  • SNDX N/A
  • PNTG 62.21
  • EPS
  • SNDX N/A
  • PNTG 0.68
  • Revenue
  • SNDX $16,000,000.00
  • PNTG $652,302,000.00
  • Revenue This Year
  • SNDX N/A
  • PNTG $29.01
  • Revenue Next Year
  • SNDX $14.15
  • PNTG $18.42
  • P/E Ratio
  • SNDX N/A
  • PNTG $40.35
  • Revenue Growth
  • SNDX N/A
  • PNTG 24.58
  • 52 Week Low
  • SNDX $12.06
  • PNTG $14.84
  • 52 Week High
  • SNDX $25.34
  • PNTG $37.13
  • Technical
  • Relative Strength Index (RSI)
  • SNDX 41.29
  • PNTG 48.34
  • Support Level
  • SNDX $12.40
  • PNTG $25.31
  • Resistance Level
  • SNDX $13.16
  • PNTG $27.78
  • Average True Range (ATR)
  • SNDX 0.65
  • PNTG 0.91
  • MACD
  • SNDX 0.10
  • PNTG 0.30
  • Stochastic Oscillator
  • SNDX 39.38
  • PNTG 88.89

About SNDX Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.

About PNTG The Pennant Group Inc.

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.

Share on Social Networks: